Literature DB >> 6799079

Alveolitis after treatment with amiodarone.

S A Riley, S E Williams, N J Cooke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6799079      PMCID： PMC1495560          DOI： 10.1136/bmj.284.6310.161

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Dangers of amiodarone and anticoagulant treatment.

Authors:  A Rees; J J Dalal; P G Reid; A H Henderson; M J Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

Review 2.  Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.

Authors:  F I Marcus; G H Fontaine; R Frank; Y Grosgogeat
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749

3.  Possible association of pneumonitis with amiodarone therapy.

Authors:  H H Rotmensch; M Liron; M Tupilski; S Laniado
Journal:  Am Heart J       Date:  1980-09       Impact factor: 4.749

4.  Amiodarone keratopathy: drug-induced lipid storage disease.

Authors:  D J D'Amico; K R Kenyon; J N Ruskin
Journal:  Arch Ophthalmol       Date:  1981-02

5.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739
  5 in total
  12 in total

1.  Amiodarone pulmonary toxicity.

Authors:  G Liss; R D Leachman
Journal:  Tex Heart Inst J       Date:  1984-06

2.  Interstitial pneumonitis with accumulation of intraalveolar macrophages, a facet amiodarone therapy.

Authors:  Lorenz H Lehmann; Wilko Weichert; Dirk Schnapauff; Rainer Dietz; Martin Stockburger
Journal:  Clin Res Cardiol       Date:  2008-10-31       Impact factor: 5.460

3.  Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity.

Authors:  M Stäubli; J Bircher; R L Galeazzi; H Remund; H Studer
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Amiodarone-induced pulmonary toxicity in the rat.

Authors:  B D Wilson; A J Jaworski; M E Donner; M L Lippmann
Journal:  Lung       Date:  1989       Impact factor: 2.584

5.  Amiodarone pulmonary toxicity: functional and ultrastructural evaluation.

Authors:  F L Liu; R D Cohen; E Downar; J W Butany; J D Edelson; A S Rebuck
Journal:  Thorax       Date:  1986-02       Impact factor: 9.139

6.  Amiodarone and pulmonary fibrosis.

Authors:  J Morera; R Vidal; F Morell; J Ruiz; L Bernadó; J R Laporte
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Amiodarone pneumonitis: three further cases with a review of published reports.

Authors:  J I Darmanata; N van Zandwijk; D R Düren; E A van Royen; W J Mooi; T A Plomp; H M Jansen; D Durrer
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

Review 8.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 9.  Idiopathic inflammatory myopathies: current and future therapeutic options.

Authors:  Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

10.  Diffuse alveolar damage syndrome associated with amiodarone therapy.

Authors:  F R Jirik; H Henning; V F Huckell; D V Ostrow
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.